Invention Grant
US09408814B2 Modified release dosage form comprising desvenlafaxine or salts thereof
有权
包含去甲文拉法辛或其盐的调释释放剂型
- Patent Title: Modified release dosage form comprising desvenlafaxine or salts thereof
- Patent Title (中): 包含去甲文拉法辛或其盐的调释释放剂型
-
Application No.: US13582440Application Date: 2011-03-21
-
Publication No.: US09408814B2Publication Date: 2016-08-09
- Inventor: Girish Kumar Jain , Premchand Dalichandji Nakhat
- Applicant: Girish Kumar Jain , Premchand Dalichandji Nakhat
- Applicant Address: IN Bandra East, Mumbai
- Assignee: WOCKHARDT LIMITED
- Current Assignee: WOCKHARDT LIMITED
- Current Assignee Address: IN Bandra East, Mumbai
- Agency: Bio Intellectual Property Services LLC (Bio IPS)
- Agent O. (Sam) Zaghmout
- Priority: IN1099/MUM/2010 20100331
- International Application: PCT/IB2011/051160 WO 20110321
- International Announcement: WO2011/121475 WO 20111006
- Main IPC: A61K31/137
- IPC: A61K31/137 ; A61P15/00 ; A61P25/00 ; A61P25/08 ; A61P25/16 ; A61P25/18 ; A61P25/22 ; A61P25/24 ; A61P3/04 ; A61K9/20 ; A61K9/28 ; A61K47/24
Abstract:
The present invention refers to a modified release pharmaceutical composition comprising desvenlafaxine or salts thereof, a release rate modifying system that controls the release of active agent(s) in both acidic and basic environments. A process of making and method of using the above-described composition is also disclosed.
Public/Granted literature
- US20130059917A1 MODIFIED RELEASE DOSAGE FORM COMPRISING DESVENLAFAXINE OR SALTS THEREOF Public/Granted day:2013-03-07
Information query
